The tisseel market research report is one of a series of new reports that provides tisseel market statistics, including the tisseel industry global market size, regional shares, competitors with the tisseel market share, detailed tisseel market segments, market trends, and opportunities, and any further data you may need to thrive in the tisseel industry. This Tisseel market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The growth in the forecast period can be attributed to the rising number of cardiac surgeries, rising cases of blood-related disorders, rising prevalence of chronic conditions leading to more surgeries, growing focus on minimally invasive surgeries, and rising trauma and accident cases. Major trends in the forecast period include technological advancements in tissue product formulations, advancements in delivery systems, advancements in hemostasis and sealant technologies, development of biodegradable and synthetic sealants, and launch of innovative products.
The growing number of surgical procedures is expected to fuel the expansion of the Tisseel market. Surgical procedures are medical interventions carried out by healthcare professionals to treat various conditions, injuries, and diseases, including cardiovascular, orthopedic, and reconstructive surgeries. The increase in surgeries is influenced by factors such as an aging population, the rising prevalence of chronic diseases, advancements in surgical methods, and a higher number of trauma and accident cases. Tisseel, a fibrin sealant, is used in high-risk surgeries such as cardiac, liver, and orthopedic operations to control bleeding, promote tissue healing, and reduce complications. For example, in 2022, the International Society of Aesthetic Plastic Surgery (ISAPS) reported a 11.2% increase in surgical procedures compared to 2021, with over 14.9 million surgeries performed globally. This upward trend in surgical procedures is contributing to the growth of the Tisseel market.
The rise in trauma and accident cases is also expected to drive market growth. Trauma and accidents, which are injuries caused by unexpected external events such as car crashes, falls, and workplace incidents, are increasing due to factors such as higher road traffic, workplace hazards, distracted driving, and environmental conditions such as extreme weather. Tisseel, a fibrin sealant made from human plasma proteins, mimics the body's natural clotting process, promoting clot formation and helping control bleeding, particularly in trauma situations. For instance, in 2023, the Transport Accident Commission in Australia reported 295 fatalities on Victorian roads, reflecting a 22.4% increase from the previous year. The rising number of trauma and accident cases is thus driving the demand for Tisseel.
The growing healthcare expenditure is expected to further support the Tisseel market. Healthcare expenditures refer to the total financial resources allocated to medical services, pharmaceuticals, and healthcare infrastructure by both public and private entities. This rise in spending is driven by factors such as an aging population, the prevalence of chronic diseases, advancements in medical technology, and increased healthcare costs. Higher healthcare expenditure leads to greater investment in advanced surgical procedures and tissue repair solutions, where Tisseel is commonly used as a hemostatic agent. For example, UK healthcare spending reached approximately $354.88 billion in 2022, reflecting a 0.7% increase from the previous year, according to the Office for National Statistics. This increase in healthcare expenditure is contributing to the market's growth.
The key company operating in the tisseel market is Baxter International Inc.
North America was the largest region in the Tisseel market in 2024. The regions covered in tisseel report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the tisseel market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.
Tisseel is a fibrin sealant used in surgical procedures to control bleeding and promote tissue adhesion. It consists of fibrinogen and thrombin, which combine to form a gel that seals tissues and aids in the healing process.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
Tisseel is used across various medical specialties, including orthopedics, cardiovascular surgery, general surgery, urological procedures, neurosurgery, ophthalmic surgery, transplants, and wound management. In orthopedics, it helps treat and prevent injuries and diseases affecting the musculoskeletal system, including bones, joints, and muscles. Available in liquid, patch, and spray forms, Tisseel is distributed through multiple channels such as direct sales, distributors, wholesalers, online sales, and retail pharmacies. It serves a range of end users, including hospitals, specialty clinics, ambulatory surgical centers, and home care settings.
The tisseel market consists of sales of prefilled syringes, surgical sealant kits, powder kits, duos, and sprays. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
The growth in the forecast period can be attributed to the rising number of cardiac surgeries, rising cases of blood-related disorders, rising prevalence of chronic conditions leading to more surgeries, growing focus on minimally invasive surgeries, and rising trauma and accident cases. Major trends in the forecast period include technological advancements in tissue product formulations, advancements in delivery systems, advancements in hemostasis and sealant technologies, development of biodegradable and synthetic sealants, and launch of innovative products.
The growing number of surgical procedures is expected to fuel the expansion of the Tisseel market. Surgical procedures are medical interventions carried out by healthcare professionals to treat various conditions, injuries, and diseases, including cardiovascular, orthopedic, and reconstructive surgeries. The increase in surgeries is influenced by factors such as an aging population, the rising prevalence of chronic diseases, advancements in surgical methods, and a higher number of trauma and accident cases. Tisseel, a fibrin sealant, is used in high-risk surgeries such as cardiac, liver, and orthopedic operations to control bleeding, promote tissue healing, and reduce complications. For example, in 2022, the International Society of Aesthetic Plastic Surgery (ISAPS) reported a 11.2% increase in surgical procedures compared to 2021, with over 14.9 million surgeries performed globally. This upward trend in surgical procedures is contributing to the growth of the Tisseel market.
The rise in trauma and accident cases is also expected to drive market growth. Trauma and accidents, which are injuries caused by unexpected external events such as car crashes, falls, and workplace incidents, are increasing due to factors such as higher road traffic, workplace hazards, distracted driving, and environmental conditions such as extreme weather. Tisseel, a fibrin sealant made from human plasma proteins, mimics the body's natural clotting process, promoting clot formation and helping control bleeding, particularly in trauma situations. For instance, in 2023, the Transport Accident Commission in Australia reported 295 fatalities on Victorian roads, reflecting a 22.4% increase from the previous year. The rising number of trauma and accident cases is thus driving the demand for Tisseel.
The growing healthcare expenditure is expected to further support the Tisseel market. Healthcare expenditures refer to the total financial resources allocated to medical services, pharmaceuticals, and healthcare infrastructure by both public and private entities. This rise in spending is driven by factors such as an aging population, the prevalence of chronic diseases, advancements in medical technology, and increased healthcare costs. Higher healthcare expenditure leads to greater investment in advanced surgical procedures and tissue repair solutions, where Tisseel is commonly used as a hemostatic agent. For example, UK healthcare spending reached approximately $354.88 billion in 2022, reflecting a 0.7% increase from the previous year, according to the Office for National Statistics. This increase in healthcare expenditure is contributing to the market's growth.
The key company operating in the tisseel market is Baxter International Inc.
North America was the largest region in the Tisseel market in 2024. The regions covered in tisseel report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the tisseel market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.
Tisseel is a fibrin sealant used in surgical procedures to control bleeding and promote tissue adhesion. It consists of fibrinogen and thrombin, which combine to form a gel that seals tissues and aids in the healing process.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
Tisseel is used across various medical specialties, including orthopedics, cardiovascular surgery, general surgery, urological procedures, neurosurgery, ophthalmic surgery, transplants, and wound management. In orthopedics, it helps treat and prevent injuries and diseases affecting the musculoskeletal system, including bones, joints, and muscles. Available in liquid, patch, and spray forms, Tisseel is distributed through multiple channels such as direct sales, distributors, wholesalers, online sales, and retail pharmacies. It serves a range of end users, including hospitals, specialty clinics, ambulatory surgical centers, and home care settings.
The tisseel market consists of sales of prefilled syringes, surgical sealant kits, powder kits, duos, and sprays. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Table of Contents
1. Executive Summary2. Tisseel Market Characteristics4. Tisseel Market Trends And Strategies5. Tisseel Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market7. Global Tisseel Pricing Analysis & Forecasts30. Global Tisseel Market Competitive Benchmarking And Dashboard31. Key Mergers And Acquisitions In The Tisseel Market32. Recent Developments In The Tisseel Market
3. Tisseel Market Biologic Drug Characteristics
6. Global Tisseel Growth Analysis And Strategic Analysis Framework
8. Tisseel Market Segmentation
9. Global Tisseel Epidemiology Of Clinical Indications
10. Tisseel Market Regional And Country Analysis
11. Asia-Pacific Tisseel Market
12. China Tisseel Market
13. India Tisseel Market
14. Japan Tisseel Market
15. Australia Tisseel Market
16. South Korea Tisseel Market
17. Western Europe Tisseel Market
18. UK Tisseel Market
19. Germany Tisseel Market
20. France Tisseel Market
21. Eastern Europe Tisseel Market
22. North America Tisseel Market
23. USA Tisseel Market
24. Canada Tisseel Market
25. South America Tisseel Market
26. Middle East Tisseel Market
27. Africa Tisseel Market
28. Tisseel Market Competitive Landscape And Company Profiles
29. Global Tisseel Market Pipeline Analysis
33. Tisseel Market High Potential Countries, Segments and Strategies
34. Appendix
Executive Summary
Tisseel Global Market Report 2025 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on tisseel market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for tisseel ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The tisseel market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:
1) By Indication: Orthopedic; Cardiovascular; General; Urological; Neurosurgery; Ophthalmic; Transplant; Wound Management2) By Formulation: Liquid; Patch; Spray
3) By Distribution Channel: Direct Sales; Distributors And Wholesalers; Online Sales; Retail Pharmacies
4) By End User: Hospitals; Specialty Clinics; Ambulatory Surgical Centers; Home Care Settings
Key Companies Profiled: Baxter International Inc
Countries: Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Companies Mentioned
- Baxter International Inc